Erasca, Inc. (ERAS)

NMS – Real vaqt narxi. Valyuta: USD

10.38

-0.06 (-0.57%)

Yopilishda: May 12, 2026, 4:00 PM EDT

07.05.2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

NEW YORK, May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

06.05.2026

Erasca to Present at the Bank of America Securities Health Care Conference

SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Bank of America Securities 2026 Health Care Conference being held at the Encore Hotel in Las Vegas, Nevada. Management will participate in a fireside chat on Wednesday, May 13, 2026, at 3:00 pm Pacific Time and will also participate in one-on-one investor meetings.

04.05.2026

Erasca, Inc. Investors Should Contact Block & Leviton LLP to Learn More About Securities Fraud Investigation

Investors who lost money in Erasca Inc. (Nasdaq: $ERAS) should contact Block & Leviton to potentially recover losses via securities fraud investigation.

04.05.2026

Buy These 3 Clinical-Stage Biotechs Under $30 With Solid Cash Runways

Clinical-stage biotech is one of the few corners of the market where a sub-$30 share price genuinely matters: small-cap oncology names can re-rate violently around a single Phase 3 readout or FDA decision, and 2026 is stacked with catalysts.

01.05.2026

SHAREHOLDER ALERT: Erasca, Inc. Investigated for Securities Fraud Violations by Block & Leviton

Boston, Massachusetts--(Newsfile Corp. - May 1, 2026) - Block & Leviton is investigating Erasca, Inc. (NASDAQ: ERAS) for potential securities law violations. Investors who have lost money in their Erasca, Inc. investment should contact the firm to learn more about how they might recover those losses.

29.04.2026

Erasca, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Boston, Massachusetts--(Newsfile Corp. - April 29, 2026) - Block & Leviton is investigating Erasca, Inc. (NASDAQ: ERAS) for potential securities law violations. Investors who have lost money in their Erasca, Inc. investment should contact the firm to learn more about how they might recover those losses.

28.04.2026

Erasca Stock Sinks 50% in Race for ‘Miracle' Cancer Drug. What's Behind the Historic Sell-Off.

Erasca is developing a competitor to Revolution Medicines' daraxonrasib.

Videolar

No Data

There is no data to display

Press-relizlar

07.05.2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

04.05.2026

Erasca, Inc. Investors Should Contact Block & Leviton LLP to Learn More About Securities Fraud Investigation

Investors who lost money in Erasca Inc. (Nasdaq: $ERAS) should contact Block & Leviton to potentially recover losses via securities fraud investigation.

01.05.2026

SHAREHOLDER ALERT: Erasca, Inc. Investigated for Securities Fraud Violations by Block & Leviton

29.04.2026

Erasca, Inc. (ERAS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Erasca, Inc. (ERAS)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

Erasca to Present at the Bank of America Securities Health Care Conference

Erasca, Inc. Investors Should Contact Block & Leviton LLP to Learn More About Securities Fraud Investigation

Buy These 3 Clinical-Stage Biotechs Under $30 With Solid Cash Runways

SHAREHOLDER ALERT: Erasca, Inc. Investigated for Securities Fraud Violations by Block & Leviton

Erasca, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Erasca Stock Sinks 50% in Race for ‘Miracle' Cancer Drug. What's Behind the Historic Sell-Off.

Videolar

No Data

Press-relizlar

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

Erasca, Inc. Investors Should Contact Block & Leviton LLP to Learn More About Securities Fraud Investigation

SHAREHOLDER ALERT: Erasca, Inc. Investigated for Securities Fraud Violations by Block & Leviton

Erasca, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

Erasca to Present at the Bank of America Securities Health Care Conference

Erasca, Inc. Investors Should Contact Block & Leviton LLP to Learn More About Securities Fraud Investigation

Buy These 3 Clinical-Stage Biotechs Under $30 With Solid Cash Runways

SHAREHOLDER ALERT: Erasca, Inc. Investigated for Securities Fraud Violations by Block & Leviton

Erasca, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Erasca Stock Sinks 50% in Race for ‘Miracle' Cancer Drug. What's Behind the Historic Sell-Off.

Videolar

No Data

Press-relizlar

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

Erasca, Inc. Investors Should Contact Block & Leviton LLP to Learn More About Securities Fraud Investigation

SHAREHOLDER ALERT: Erasca, Inc. Investigated for Securities Fraud Violations by Block & Leviton

Erasca, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Search stocks

Erasca, Inc. (ERAS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Erasca, Inc. (ERAS)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

Erasca to Present at the Bank of America Securities Health Care Conference

Erasca, Inc. Investors Should Contact Block & Leviton LLP to Learn More About Securities Fraud Investigation

Buy These 3 Clinical-Stage Biotechs Under $30 With Solid Cash Runways

SHAREHOLDER ALERT: Erasca, Inc. Investigated for Securities Fraud Violations by Block & Leviton

Erasca, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Erasca Stock Sinks 50% in Race for ‘Miracle' Cancer Drug. What's Behind the Historic Sell-Off.

Videolar

No Data

Press-relizlar

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

Erasca, Inc. Investors Should Contact Block & Leviton LLP to Learn More About Securities Fraud Investigation

SHAREHOLDER ALERT: Erasca, Inc. Investigated for Securities Fraud Violations by Block & Leviton

Erasca, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

Erasca to Present at the Bank of America Securities Health Care Conference

Erasca, Inc. Investors Should Contact Block & Leviton LLP to Learn More About Securities Fraud Investigation

Buy These 3 Clinical-Stage Biotechs Under $30 With Solid Cash Runways

SHAREHOLDER ALERT: Erasca, Inc. Investigated for Securities Fraud Violations by Block & Leviton

Erasca, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Erasca Stock Sinks 50% in Race for ‘Miracle' Cancer Drug. What's Behind the Historic Sell-Off.

Videolar

No Data

Press-relizlar

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS

Erasca, Inc. Investors Should Contact Block & Leviton LLP to Learn More About Securities Fraud Investigation

SHAREHOLDER ALERT: Erasca, Inc. Investigated for Securities Fraud Violations by Block & Leviton

Erasca, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses